← Back to Search

Behavioural Intervention

Internet Auditory Rehabilitation for Hearing Loss

N/A
Waitlist Available
Led By Jill Preminger, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pass a thinking skills screening
Between the ages of 45 and 85
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks post baseline, and 6 months post baseline
Awards & highlights

Study Summary

This trial will test whether the "I Manage my hearing loss" program can help people who have failed a hearing screening to visit an audiologist.

Who is the study for?
This trial is for adults aged 45-85 who have failed a hearing screening or have similar hearing loss on an audiogram, can understand health information, and pass a cognitive test. They should not have ear diseases, nor should they have previously seen an audiologist or used a hearing aid.Check my eligibility
What is being tested?
The study tests the 'iManage my hearing loss' program to see if it encourages people who've failed a hearing screening to visit an audiologist. It educates about the importance of addressing hearing issues and seeking support from others.See study design
What are the potential side effects?
Since 'iManage' is an educational program rather than a medical treatment, traditional side effects are not applicable. However, participants may experience emotional or psychological responses as they learn about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I passed a cognitive function test.
Select...
I am between 45 and 85 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks post baseline, and 6 months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks post baseline, and 6 months post baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Audiologist visit
Secondary outcome measures
Change on the Health Belief Questionnaire, a survey that measures attitudes about the 6 constructs of the Health Belief Model as related to seeking hearing healthcare
Change on the Readiness for Change Questionnaire, a single-item questionnaire that attempts to place the participant on a continuum regarding readiness for hearing healthcare as outline by the Transtheoretical Model.
Total score on the Hearing Loss Support Scale, a questionnaire that measures self-perceived informational and emotional support from family, peers, and healthcare providers about managing hearing loss.
Other outcome measures
A focus group of individuals who completed the iManage program to learn participants perceptions about the content, benefits and drawbacks of the iManage program
Mean scores on the Audiology Decision Making Scale, a scale designed to measure preparedness for decision making for 13 specific decision processes
Program completion
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Program GroupExperimental Treatment1 Intervention
Following a failed hearing screening, participants will be offered the standard of care (information sheet recommending a comprehensive hearing evaluation) and asked to complete the iManage Program. Six months after the screening participants will be asked if they visited an audiologist.
Group II: Delayed Program GroupActive Control1 Intervention
Following a failed hearing screening, participants will be offered the standard of care (information sheet recommending a comprehensive hearing evaluation). Six months after the screening participants will be asked if they visited an audiologist and they will be given the opportunity to complete the iManage Program.

Find a Location

Who is running the clinical trial?

William Demant Foundation (Formerly known as the Oticon Foundation)UNKNOWN
University of LouisvilleLead Sponsor
338 Previous Clinical Trials
75,881 Total Patients Enrolled
Jill Preminger, PhDPrincipal InvestigatorProfessor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still able to participate in this research endeavor?

"Clinicaltrials.gov indicates that this clinical trial, first listed on August 17th 2021, is actively seeking participants. The details of the study were most recently modified on September 3rd 2022."

Answered by AI

Is eligibility open for enrollment into this research project?

"To qualify, prospective participants must have auditory impairment and be between 45 to 85 years old. Currently, 40 individuals are needed for the medical trial."

Answered by AI

What is the aggregate number of individuals participating in this research study?

"Affirmative. According to clinicaltrials.gov, recruitment for this medical trial is currently ongoing. First posted on August 17th 2021 and last updated September 3rd 2022, the study seeks 40 participants from 1 research centre."

Answered by AI

Is there an age restriction for enrollment in this experiment?

"According to the specified entry requirements for this clinical trial, eligible patients must range in age from 45 to 85 years old."

Answered by AI
~28 spots leftby Apr 2025